Specsavers profits rise as dividends return

Specsavers profits jump as the optometry chain reports pre‑tax earnings that surged by more than a quarter, prompting a return to dividend payouts for its owners.

Profit surge fuels dividend restart

The retailer posted a pre‑tax profit of £429.7 million for the year ending February, up from the previous period. Sales climbed 7 per cent to £4.3 billion despite a challenging macro environment.

Following the earnings lift, the company paid a £12 million dividend to Specsavers International Healthcare Limited, the vehicle controlled by founders Doug and Dame Mary Perkins.

The payout marks a return to dividends after Specsavers paused them in the previous financial year because of economic and political uncertainty and its own significant investment and expansion plans. The business had paid dividends of around £15m in each of the two years before the pause.

A spokesperson said the resumption “reflects the strength of the business and confidence in its future performance.” The comment shows that the firm is still investing in long‑term growth while returning cash to shareholders.

The decision to restart payouts came after a period in which the board deliberately held back distributions to preserve liquidity amid heightened economic and political uncertainty. During that pause the company also allocated significant resources toward opening new sites and upgrading existing facilities, reinforcing its market presence.

Management emphasized that the dividend level aligns with historic practice, showing a strategic intent to balance shareholder returns with ongoing capital projects. By maintaining a disciplined approach to cost management, the group has been able to generate surplus cash without compromising its ambition to expand the brand footprint.

Partner payouts and expansion plans

In addition to the owner dividend, the chain distributed almost £258 million to its independent store partners, a rise from £239 million the year before. The network now spans close to 3,000 optometry, audiology and ophthalmology locations in at least eight countries, with more than 1,200 sites in the United Kingdom alone.

The group attributes higher profitability to keeping costs flat and trimming “non‑value add activities.” It said inflationary pressure on wages, utilities and supplier costs was largely absorbed rather than shifted to shoppers.

Digital services are also being expanded as customers blend in‑store visits with online interactions. The firm noted that regional strategies are under continual review as market conditions evolve and regulatory scrutiny grows.

While the numbers are clear, if a bit messy, the company’s cash position appears solid.

Looking ahead, the chain’s ability to sustain its margin will likely hinge on how well it balances price pressures with its value promise. Should inflation ease, the firm could keep its cost‑containment approach and possibly lift partner payouts further. Conversely, any new fiscal headwinds might temper that optimism.

The Perkins couple, who founded the business in Guernsey in 1983, remain at the helm of the privately owned enterprise. Their combined wealth was estimated at £1.4 billion by a recent rich list.

The partnership model continues to be a cornerstone of the company’s operating philosophy, with independent franchisees sharing in overall performance through profit‑linked distributions. This collaborative framework encourages local entrepreneurs to uphold service standards while benefiting from the scale and brand equity of the larger group.

Investments in technology are being directed toward a seamless omnichannel experience, allowing customers to schedule appointments, order eyewear, and access after‑care support through a unified platform. By integrating these digital touchpoints, the retailer aims to strengthen loyalty and capture additional revenue streams without eroding its reputation for affordable care.

Regional leadership teams regularly assess market trends, adjusting store footprints and service offerings to align with shifting consumer expectations and emerging regulatory requirements. This proactive stance helps the chain stay resilient in the face of evolving health‑care policies and competitive pressures.